The Enterprise Value as of December 2024 (TTM) for NovaBay Pharmaceuticals, Inc. (NBY) is 2.93M

According to NovaBay Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.93M. This represents a change of 15.70% compared to the average of 2.53M of the last 4 quarters.

NovaBay Pharmaceuticals, Inc. (NBY) Historical Enterprise Value (quarterly & annually)

How has NBY Enterprise Value performed in the past?

The mean historical Enterprise Value of NovaBay Pharmaceuticals, Inc. over the last ten years is 7.76M. The current 2.93M Enterprise Value has changed 3.67% with respect to the historical average. Over the past ten years (40 quarters), NBY's Enterprise Value was at its highest in in the September 2017 quarter at 64.27M. The Enterprise Value was at its lowest in in the September 2016 quarter at -9430000.00.

NovaBay Pharmaceuticals, Inc. (NBY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NovaBay Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NovaBay Pharmaceuticals, Inc. (NBY) Average Enterprise Value

How has NBY Enterprise Value performed in the past?

The current Enterprise Value of NovaBay Pharmaceuticals, Inc. (NBY) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

NovaBay Pharmaceuticals, Inc. (NBY) Enterprise Value vs. Peers

How is NBY’s Enterprise Value compared to its peers?

NovaBay Pharmaceuticals, Inc.’s Enterprise Value is less than Immix Biopharma, Inc. (40.00M), greater than CNS Pharmaceuticals, Inc. (-670138.00), less than eFFECTOR Therapeutics, Inc. (4.74M), greater than Navidea Biopharmaceuticals, Inc. (-2595051.00), less than Sonnet BioTherapeutics Holdings, Inc. (4.42M), greater than ZyVersa Therapeutics, Inc. (2.67M), less than VectivBio Holding AG (848.58M), greater than AVROBIO, Inc. (-85302404.00), greater than Zura Bio Limited (-33475334.00), greater than Altamira Therapeutics Ltd. (500.65K), greater than Enveric Biosciences, Inc. (107.09K), greater than Palisade Bio, Inc. (-2814599.00), greater than Phio Pharmaceuticals Corp. (-3152934.00),

Build a custom stock screener for NovaBay Pharmaceuticals, Inc. (NBY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NovaBay Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NovaBay Pharmaceuticals, Inc. (NBY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NovaBay Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.